Industry leading team

At Polpharma Biologics, our passion for excellence begins at the top.

With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals, our international management team brings both knowledge and passion to every project.

Jerzy Starak

Founder and Owner Polpharma Biologics Group

Jerzy Starak is one of the Polish entrepreneurs whose activities contributed to the modernization and innovative development of the Polish economy. A visionary full of courage and determination in realizing ever new business challenges.

Jerzy Starak played a key role in the development of the Polish pharmaceutical sector. In 2000, he became the owner of Polpharma S.A. Ambitious modernization processes, huge investments in research and laboratory infrastructure and cooperation with top class specialists made Polpharma S.A. a European leader in the production of generic drugs.

In 2010, Jerzy Starak, inspired by the global direction in pharmaceutical development, made the decision to expand his business activities into production of biological drugs. Already in 2012, the first Research and Development Center opened in the Gdańsk Science and Technology Park and in 2020 another modern Center for Development and Production on an industrial scale began its activities in Warsaw-Duchnice. Today, Polpharma Biologics is the largest biosimilar drug development company in this part of Europe, operating in partnerships with global leaders in the pharmaceutical market.

Supervisory Board Polpharma Biologics Group

Next
Emmanuelle Lepine

Chairwoman

Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Dr Joerg Windisch

Vice Chairman

Polpharma Biologics Group

“We value everyone equally and always treat each other with respect”

Next
Dr Michel Cup

Supervisory Board Member

Polpharma Biologics Group

“We care about being respectful and transparent”

Next
Dr Konstantin Matentzoglu

Supervisory Board Member

Polpharma Biologics Group

“We work with dedication and find innovative solutions”

Next
Gertjan Noordermeer

Supervisory Board Member

Polpharma Biologics Group

Core Management Team

“We care about being respectful and transparent”

Next
Dr Konstantin Matentzoglu

Delegated Supervisory Board Member

Polpharma Biologics Group

“We work with dedication and find innovative solutions”

Next
Dr Adriana Kiędzierska-Mencfeld

President of the Management Board Polpharma Biologics SA

Chief Operating Officer Polpharma Biologics Group

“Our patients expect and deserve high quality and innovative medicines”

Next
Mathieu Ballie

Chief Quality Officer

Polpharma Biologics Group

"We care about delivering on our commitments"

Next
Hannes Teissl

Chief Business Officer

Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Jakub Walkowiak

Chief Financial Officer

Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Dr Joerg Windisch

Chief Scientific Officer

Polpharma Biologics Group

Extended Management Team

“We are experts in managing projects, transparent communicators and always deliver on our commitments”

Next
Alexandra Moulson

Chief eXcellence Officer

Polpharma Biologics Group

“We work with dedication and find innovative solutions”

Next
Frederic Papp

Chief Technical Officer

Polpharma Biologics Group

„Teamwork is the key to unlocking our collective potential and achieving greatness together"

Next
Justyna Tyborowska

Chief People Officer

Polpharma Biologics Group

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.